Olga O. Gonchar

4 Bogomoletz St
01024, Ukraine

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Evaluation of the neurotrophic peptide mixture in pathogenetic therapy of patients with Parkinson's disease.

Evaluation of the neurotrophic peptide mixture in pathogenetic therapy of patients with Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: February 08, 2025

Water-soluble pristine C60 fullerenes attenuate isometric muscle force reduction in a rat acute inflammatory pain model.

Water-soluble pristine C60 fullerenes attenuate isometric muscle force reduction in a rat acute inflammatory pain model.

Journal: BMC musculoskeletal disorders

Published: October 12, 2022

C60 fullerene attenuates muscle force reduction in a rat during fatigue development.

C60 fullerene attenuates muscle force reduction in a rat during fatigue development.

Journal: Heliyon

Published: September 06, 2022

C60 Fullerene Reduces 3-Nitropropionic Acid-Induced Oxidative Stress Disorders and Mitochondrial Dysfunction in Rats by Modulation of p53, Bcl-2 and Nrf2 Targeted Proteins.

C60 Fullerene Reduces 3-Nitropropionic Acid-Induced Oxidative Stress Disorders and Mitochondrial Dysfunction in Rats by Modulation of p53, Bcl-2 and Nrf2 Targeted Proteins.

Journal: International journal of molecular sciences

Published: April 20, 2021

C60 fullerenes increase the intensity of rotational movements in non‑anesthetized hemiparkinsonic rats.

C60 fullerenes increase the intensity of rotational movements in non‑anesthetized hemiparkinsonic rats.

Journal: Acta neurobiologiae experimentalis

Published: March 28, 2020

Fatigue-induced Fos immunoreactivity within the lumbar cord and amygdala decreases after С60 fullerene pretreatment.

Fatigue-induced Fos immunoreactivity within the lumbar cord and amygdala decreases after С60 fullerene pretreatment.

Journal: Scientific reports

Published: January 19, 2020

C60 Fullerene Prevents Restraint Stress-Induced Oxidative Disorders in Rat Tissues: Possible Involvement of the Nrf2/ARE-Antioxidant Pathway.

C60 Fullerene Prevents Restraint Stress-Induced Oxidative Disorders in Rat Tissues: Possible Involvement of the Nrf2/ARE-Antioxidant Pathway.

Journal: Oxidative medicine and cellular longevity

Published: July 11, 2018

C60 Fullerenes Diminish Muscle Fatigue in Rats Comparable to N-acetylcysteine or β-Alanine.

C60 Fullerenes Diminish Muscle Fatigue in Rats Comparable to N-acetylcysteine or β-Alanine.

Journal: Frontiers in physiology

Published: February 05, 2018

C60 fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue.

C60 fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue.

Journal: Journal of nanobiotechnology

Published: November 07, 2016

Moderate hypoxia/hyperoxia attenuates acute hypoxia-induced oxidative damage and improves antioxidant defense in lung mitochondria.

Moderate hypoxia/hyperoxia attenuates acute hypoxia-induced oxidative damage and improves antioxidant defense in lung mitochondria.

Journal: Acta physiologica Hungarica

Published: December 15, 2012

Effect of moderate hypoxia/reoxygenation on mitochondrial adaptation to acute severe hypoxia.

Effect of moderate hypoxia/reoxygenation on mitochondrial adaptation to acute severe hypoxia.

Journal: Acta biologica Hungarica

Published: July 09, 2009

Corrections of prooxidant-antioxidant homeostasis of organism under hypoxia of different genesis by yackton, a new pharmacological preparation.

Corrections of prooxidant-antioxidant homeostasis of organism under hypoxia of different genesis by yackton, a new pharmacological preparation.

Journal: Acta physiologica et pharmacologica Bulgarica

Published: October 23, 2003

Showing 1-12 of 12

Last Updated: 09/26/2026